Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modulation of GABA-A Receptors and Axial Motor Impairments in Parkinson Disease-Flumazenil Arm

NCT03462641 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT03462641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03462641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modulation of GABA-A Receptors and Axial Motor Impairments in Parkinson Disease-Flumazenil Arm
Lead sponsor
University of Michigan
Phase
Phase 1/2
Overall status
Completed
Start date
March 9, 2018
Completion date
June 4, 2021
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease